Related references
Note: Only part of the references are listed.Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients
Akihito Kawazoe et al.
GASTRIC CANCER (2017)
Decitabine Inhibits Tumor Cell Proliferation and Up-Regulates E-Cadherin Expression in Epstein-Barr Virus-Associated Gastric Cancer
Munetaka Nakamura et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype
J. Yu et al.
ONCOGENE (2017)
Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review
Joana Ribeiro et al.
FUTURE ONCOLOGY (2017)
Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells
Keisuke Matsusaka et al.
JOURNAL OF PATHOLOGY (2017)
An atlas of human long non-coding RNAs with accurate 5′ ends
Chung-Chau Hon et al.
NATURE (2017)
Gastric Cancer in the Era of Precision Medicine
Xi Liu et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Global profiling of viral and cellular non-coding RNAs in Epstein Barr virus-induced lymphoblastoid cell lines and released exosome cargos
Alessia Gallo et al.
CANCER LETTERS (2017)
Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
Changqing Ma et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes
Mirang Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn et al.
NATURE REVIEWS GENETICS (2016)
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis
Aldo Giudice et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection
Diogo Piedade et al.
VIRUSES-BASEL (2016)
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1
Yali Song et al.
ONCOTARGET (2016)
SNHG8 is identified as a key regulator of epstein-barr virus(EBV)--associated gastric cancer by an integrative analysis of IncRNA and mRNA expression
Tao Huang et al.
ONCOTARGET (2016)
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
Sarah Derks et al.
ONCOTARGET (2016)
Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD
Hyoji Kim et al.
CANCER LETTERS (2015)
Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinoma
Seung Myung Dong et al.
JOURNAL OF MICROBIOLOGY (2015)
Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region
Aron R. Marquitz et al.
JOURNAL OF VIROLOGY (2015)
Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas
Michael J. Strong et al.
JOURNAL OF VIROLOGY (2015)
Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis
Aya Shinozaki-Ushiku et al.
JOURNAL OF VIROLOGY (2015)
New Noncoding Lytic Transcripts Derived from the Epstein-Barr Virus Latency Origin of Replication, oriP, Are Hyperedited, Bind the Paraspeckle Protein, NONO/p54nrb, and Support Viral Lytic Transcription
Subing Cao et al.
JOURNAL OF VIROLOGY (2015)
The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells
Xiaochen Lin et al.
PLOS PATHOGENS (2015)
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival
Dong Kang et al.
PLOS PATHOGENS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Clustered MicroRNAs of the Epstein-Barr Virus Cooperatively Downregulate an Epithelial Cell-Specific Metastasis Suppressor
Teru Kanda et al.
JOURNAL OF VIROLOGY (2015)
Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics
Jiri Mayer et al.
BMC CANCER (2014)
Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia
Christopher B. Benton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Expression Profile of MicroRNAs in Epstein-Barr Virus-Infected AGS Gastric Carcinoma Cells
Aron R. Marquitz et al.
JOURNAL OF VIROLOGY (2014)
MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
Yu-Jin Jung et al.
JOURNAL OF VIROLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Treatment of early gastric cancer in the Western World
Elfriede Bollschweiler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Decitabine reactivated pathways in platinum resistant ovarian cancer
Fang Fang et al.
ONCOTARGET (2014)
Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas
Toshiyuki Okada et al.
CANCER SCIENCE (2013)
Role of DNA methylation in the development of Epstein-Barr virus-associated gastric carcinoma
Mari Saito et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63
F. Conforti et al.
ONCOGENE (2013)
Epstein-Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
Atsushi Kaneda et al.
CANCER RESEARCH (2012)
Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells
Feng Yang et al.
FEBS JOURNAL (2012)
Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
Hisashi Iizasa et al.
VIRUSES-BASEL (2012)
Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile
Weihua Tang et al.
INFECTIOUS AGENTS AND CANCER (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Classification of Epstein-Barr Virus-Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes
Keisuke Matsusaka et al.
CANCER RESEARCH (2011)
The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines
Do Nyun Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Epstein-Barr virus-associated gastric carcinoma
Masashi Fukayama et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
Jin Qiu et al.
PLOS PATHOGENS (2011)
Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma
Aya Shinozaki et al.
CANCER RESEARCH (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Gastric Cancer: An Infectious Disease
M. Blanca Piazuelo et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency
Hisashi Iizasa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing
Shu-Jen Chen et al.
PLOS ONE (2010)
Lost in translation: an assessment and perspective for computational microRNA target identification
Panagiotis Alexiou et al.
BIOINFORMATICS (2009)
Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma
Rumi Hino et al.
CANCER RESEARCH (2009)
Stimulus Duration and Response Time Independently Influence the Kinetics of Lytic Cycle Reactivation of Epstein-Barr Virus
Jill Countryman et al.
JOURNAL OF VIROLOGY (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia
Hans Helmut Niller et al.
SEMINARS IN CANCER BIOLOGY (2009)
Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent
Lassad Oussaief et al.
VIROLOGY (2009)
Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors
Jill K. Countryman et al.
JOURNAL OF VIROLOGY (2008)
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
William M. Merritt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C Agonists
Jianjiang Ye et al.
JOURNAL OF VIROLOGY (2007)
Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
Sieta P. Rao et al.
MOLECULAR CANCER (2007)
Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH2-terminal kinase signaling
Chia-Lung Tsai et al.
CANCER RESEARCH (2006)
CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus
Moon-Sung Chang et al.
CLINICAL CANCER RESEARCH (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus
M Kusano et al.
CANCER (2006)
MicroRNAs direct rapid deadenylation of mRNA
LG Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epstein-Barr virus MicroRNAs are evolutionarily conserved and differentially expressed
Xuezhong Cai et al.
PLOS PATHOGENS (2006)
Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas
Bing Luo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts
HL Chen et al.
JOURNAL OF VIROLOGY (2005)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells
Y Isobe et al.
CANCER RESEARCH (2004)
Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus
JM Chong et al.
CANCER SCIENCE (2003)
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation
QN Vo et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the down-regulation of E-cadherin gene expression via activation of DNA methyltransferases
CN Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma
GH Kang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death
GJ Inman et al.
JOURNAL OF VIROLOGY (2001)